Corneal cross linking (CCL) is a new method of treatment for keratoconus (a corneal disease) at an early stage with UV light and vitamin B2.
This involves removing the epithelium, the most superficial layer of the cornea. Then liquid Vitamin B2 (riboflavin) is applied to the cornea followed by the application of UV light to the eye. The combination of ultraviolet light and vitamin B2 cause fibres within the cornea to cross-link.
This method can halt the spread of keratoconus which, over time, might otherwise progress even further.
Competent medical advice
If this new treatment is of interest to you, we would be happy to inform you about options, experiences and possible complications.
Call for an individual consultation: +49 611 360 220.
You can also use our contact form.
Or send an email to firstname.lastname@example.org